$21.530
+0.041 (+0.19%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
DAWN Prediction & Forecast by Similar Chart Analysis
Alphio's DAWN stock price prediction model matches the current Day One Biopharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.51 (-0.09%). The 1-week path is $21.79 (+1.22%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Day One Biopharmaceuticals Inc Stock?
Day One Biopharmaceuticals Inc (DAWN) is not a good buy for a beginner, long-term investor at this time. The stock is being acquired by Servier at a fixed price of $21.50 per share, which limits any upside potential. The acquisition has already been finalized, and the stock price is trading at the acquisition price, leaving no room for growth or significant returns.
DAWN stock price ended at $21.53 on Wednesday, after rising +0.19%
Day One Biopharmaceuticals Inc (DAWN) last closed at $21.53, gaining +0.19%. These facts feed the 1-day and 1-week DAWN price prediction above.
Forecast Drivers
Day One Biopharmaceuticals Inc (DAWN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches DAWN, ranked by similarity.
Seasonality analysis for DAWN
Historically the probability of a positive August return for DAWN is 0.00%. February offers the highest probability of a positive month at 65.52%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.